Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Franco Rongioletti and Cristina Mugheddu.
Connection Strength

3.130
  1. Safety of secukinumab treatment in COVID-19 affected psoriatic patients. Dermatol Ther. 2021 Jan; 34(1):e14710.
    View in: PubMed
    Score: 0.922
  2. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management. J Eur Acad Dermatol Venereol. 2020 Aug; 34(8):e376-e378.
    View in: PubMed
    Score: 0.885
  3. Successful guselkumab treatment in a psoriatic patient affected with Cornelia de Lange syndrome, and prosecution during the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13433.
    View in: PubMed
    Score: 0.879
  4. Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13722.
    View in: PubMed
    Score: 0.222
  5. Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy). J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e247-e248.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.